Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) EBT Margin (2016 - 2025)

Angiodynamics (ANGO) has disclosed EBT Margin for 16 consecutive years, with 8.0% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 689.0% year-over-year to 8.0%, compared with a TTM value of 9.02% through Nov 2025, up 7384.0%, and an annual FY2025 reading of 11.63%, up 5142.0% over the prior year.
  • EBT Margin was 8.0% for Q4 2025 at Angiodynamics, up from 14.31% in the prior quarter.
  • Across five years, EBT Margin topped out at 44.31% in Q3 2023 and bottomed at 265.68% in Q1 2024.
  • Average EBT Margin over 5 years is 23.14%, with a median of 11.65% recorded in 2021.
  • The sharpest move saw EBT Margin crashed -25370bps in 2024, then surged 25955bps in 2025.
  • Year by year, EBT Margin stood at 11.32% in 2021, then increased by 6bps to 10.59% in 2022, then tumbled by -51bps to 15.96% in 2023, then increased by 7bps to 14.89% in 2024, then skyrocketed by 46bps to 8.0% in 2025.
  • Business Quant data shows EBT Margin for ANGO at 8.0% in Q4 2025, 14.31% in Q3 2025, and 7.62% in Q2 2025.